4//SEC Filing
Anand Bhaskar 4
Accession 0001890784-25-000003
CIK 0001599298other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:45 PM ET
Size
5.6 KB
Accession
0001890784-25-000003
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-09-18+50,000→ 50,000 totalExercise: $19.23Exp: 2035-09-18→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The option was granted on September 18, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on September 18, 2026.
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:45 PM ET
- Size
- 5.6 KB